Literature DB >> 27865052

Retention in care and reasons for discontinuation of lifelong antiretroviral therapy in a cohort of Cameroonian pregnant and breastfeeding HIV-positive women initiating 'Option B+' in the South West Region.

Pascal N Atanga1,2, Harrison T Ndetan3,4, Eric A Achidi5, Henry D Meriki6,7, Michael Hoelscher2,8, Arne Kroidl2,9.   

Abstract

OBJECTIVE: To assess linkage and retention in care along the PMTCT cascade in HIV-positive pregnant and breastfeeding women initiating Option B+ in Cameroon.
METHODS: We prospectively determined uptake of HIV testing and counselling (HTC), uptake of ART and retention in care after Option B+ initiation between October 2013 and December 2014 in pregnant and breastfeeding women from five sites within the Kumba Health District. Retention in care was assessed over at least 12 months follow-up and estimated by Kaplan-Meier analysis. During follow-up, tracing outcomes and reasons for discontinuing treatment were documented.
RESULTS: The uptake of HTC of 5813 women with unknown HIV status was 98.5%, 251 (4.4%) were newly diagnosed HIV positive, and ART uptake in women eligible to start Option B+ was 96.8%. We enrolled 268 women initiating lifelong ART in the follow-up. Overall, 65 (24.3%) discontinued treatment, either defined by loss to follow-up (44.6%) or actively stopped treatment (55.8%). Retention in care was 88.0% and 81.1% at 6 and 12 months, respectively. Discontinuation was significantly associated in multivariate analysis with small sites and high staff turnover [aOR 2.5 (95% CI 1.6, 3.9), P < 0.001]. Main reasons for stopping treatment were HIV status denial and stigma (52.8%), religious reasons (25.0%) and lack of transport fare (11.1%).
CONCLUSION: We observed good uptake of HTC, ART and retention in care, which declined over time. Discontinuation of Option B+ was highest at small sites with a high staff turnover. Improved staffing, adequate task shifting and community interventions to track defaulters including reducing stigma and religious beliefs may improve Option B+ retention.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  Cameroon; Option B+; prevention of mother-to-child transmission; retention in care

Mesh:

Year:  2016        PMID: 27865052     DOI: 10.1111/tmi.12816

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  17 in total

1.  Retention in HIV Care During Pregnancy and the Postpartum Period in the Option B+ Era: Systematic Review and Meta-Analysis of Studies in Africa.

Authors:  Brandon A Knettel; Cody Cichowitz; James Samwel Ngocho; Elizabeth T Knippler; Lilian N Chumba; Blandina T Mmbaga; Melissa H Watt
Journal:  J Acquir Immune Defic Syndr       Date:  2018-04-15       Impact factor: 3.731

2.  Vulnerable at Each Step in the PMTCT Care Cascade: High Loss to Follow Up During Pregnancy and the Postpartum Period in Tanzania.

Authors:  Cody Cichowitz; Festo Mazuguni; Linda Minja; Prosper Njau; Gretchen Antelman; James Ngocho; Brandon A Knettel; Melissa H Watt; Blandina T Mmbaga
Journal:  AIDS Behav       Date:  2019-07

3.  Infant Human Immunodeficiency Virus-free Survival in the Era of Universal Antiretroviral Therapy for Pregnant and Breastfeeding Women: A Community-based Cohort Study From Rural Zambia.

Authors:  Benjamin H Chi; Wilbroad Mutale; Jennifer Winston; Winifreda Phiri; Joan T Price; Angel Mwiche; Helen Ayles; Jeffrey S A Stringer
Journal:  Pediatr Infect Dis J       Date:  2018-11       Impact factor: 2.129

Review 4.  eHealth and Prevention of Mother-to-Child Transmission of HIV.

Authors:  Grace John-Stewart
Journal:  Curr HIV/AIDS Rep       Date:  2018-08       Impact factor: 5.071

5.  Predictors of postpartum HIV care engagement for women enrolled in prevention of mother-to-child transmission (PMTCT) programs in Tanzania.

Authors:  Melissa H Watt; Cody Cichowitz; Godfrey Kisigo; Linda Minja; Brandon A Knettel; Elizabeth T Knippler; James Ngocho; Preeti Manavalan; Blandina T Mmbaga
Journal:  AIDS Care       Date:  2018-11-22

6.  Measuring retention in HIV care: the impact of data sources and definitions using routine data.

Authors:  Tamsin K Phillips; Catherine Orrell; Kirsty Brittain; Allison Zerbe; Elaine J Abrams; Landon Myer
Journal:  AIDS       Date:  2020-04-01       Impact factor: 4.632

7.  A group randomized trial using an appointment system to improve adherence to ART at reproductive and child health clinics implementing Option B+ in Tanzania.

Authors:  Dennis Ross-Degnan; John Chalker; Jafary Liana; Mwikemo Deborah Kajoka; Richard Valimba; Suleiman Kimatta; Angel Dillip; Catherine Vialle-Valentin; Martha Embrey; Rachel Lieber; Keith Johnson
Journal:  PLoS One       Date:  2017-09-28       Impact factor: 3.240

8.  Understanding women's uptake and adherence in Option B+ for prevention of mother-to-child HIV transmission in Papua, Indonesia: A qualitative study.

Authors:  Christina Lumbantoruan; Michelle Kermode; Aloisius Giyai; Agnes Ang; Margaret Kelaher
Journal:  PLoS One       Date:  2018-06-18       Impact factor: 3.240

9.  Same-day antiretroviral therapy (ART) initiation in pregnancy is not associated with viral suppression or engagement in care: A cohort study.

Authors:  Nontokozo Langwenya; Tamsin K Phillips; Kirsty Brittain; Allison Zerbe; Elaine J Abrams; Landon Myer
Journal:  J Int AIDS Soc       Date:  2018-06       Impact factor: 5.396

10.  Using a composite adherence tool to assess ART response and risk factors of poor adherence in pregnant and breastfeeding HIV-positive Cameroonian women at 6 and 12 months after initiating option B.

Authors:  Pascal N Atanga; Harrison T Ndetan; Peter N Fon; Henry D Meriki; Tih P Muffih; Eric A Achidi; Michael Hoelscher; Arne Kroidl
Journal:  BMC Pregnancy Childbirth       Date:  2018-10-25       Impact factor: 3.007

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.